Loading...

Loading...

Merck's Winrevair Reduces Death Risk in PAH Patients
By MBN Staff - Thu, 11/28/2024 - 10:54
Merck reports that Winrevair reduces death risk in advanced pulmonary arterial hypertension (PAH) patients, offering a new treatment option.

https://mexicobusiness.news/tag/pah
More Health
FDA Approves Winrevair: Breakthrough in PAH Treatment
By MBN Staff - Wed, 03/27/2024 - 16:00
Merck's Winrevair targets PAH's root cause, offering hope beyond symptom management. FDA approval marks a milestone in cardiovascular care.